Irreversible Electroporation Ablation for Colorectal Metastases to the Lung

Completed · Not applicable

Conditions studied: Colorectal Metastases to the Lung

In brief

The investigators are investigating the use of a new cancer treatment called Irreversible Electroporation (IRE). This treatment delivers electrical energy between two needles placed in a cancer. The electrical energy causes cells to die. While this has been used in patients for different applications, the investigators are trying to understand how safe and well it works in colon cancer that has spread to the lung. Once the irreversible electroporation procedure is completed during the operation, the surgeon will then remove the cancer according to standard procedure. As part of the study, they will be measuring safety of the electrical energy delivered and will be reviewing the resected specimen under the microscope.

Key facts

Study ID
NCT02461550
Run by
Memorial Sloan Kettering Cancer Center
People needed
2
Starts
2015-05-01
Expected to finish
2017-02-01
Last updated by the study team
2018-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.